Prospective, Randomized Trial of 3 Rapamycin-Eluting Stents With Different Polymer Coating Strategies For The Reduction of Coronary Restenosis (ISAR-TEST-3)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Dec 2009

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Sirolimus (Primary)
Indications Coronary artery disease; Coronary artery restenosis; Coronary disorders; Myocardial ischaemia
Focus Therapeutic Use
Acronyms ISAR-TEST-3

31 Mar 2009 Results presented at the 58th Annual Scientific Session of the American College of Cardiology (ACC-2009).
10 Jan 2008 Status changed from in progress to completed.
26 Oct 2006 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com